Official Journal of the International Alliance for Biological StandardizationBiologicals provides a modern and multidisciplinary international forum for the publication of research that advances the development, manufacturing, quality control, standardization, safety, efficacy, and regulatory aspects of human and veterinary biological products derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern. Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.Research Areas IncludeAreas relevant to biologicals for human and veterinary use such as:• Bacterial vaccines • Blood products • Cell biology • Cell culture technology • Cellular immunology • Cytokines and allied mediators • Diagnostics • Downstream processing • Gene transfer and expression • General bacteriology • General virology, endogenous and adventitious viruses • Hormones • Immunochemistry • Molecular biology • Monoclonal antibodies • Parasitology • Prion and prion disease • Protein chemistry • Toxins • Toxoids • Viral vaccines
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterBiomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Biomaterials Advances and Biomaterials and Biosystems . As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!
The Official Journal of the European Alliance of Medical and Biological Engineering and Science (EAMBES).Biomedical Signal Processing and Control aims to provide a cross-disciplinary international forum for the interchange of information on research in the measurement and analysis of signals and images in clinical medicine and the biological sciences. Emphasis is placed on contributions dealing with the practical, applications-led research on the use of methods and devices in clinical diagnosis, patient monitoring and management.Biomedical Signal Processing and Control reflects the main areas in which these methods are being used and developed at the interface of both engineering and clinical science. The scope of the journal is defined to include relevant review papers, technical notes, short communications and letters. Tutorial papers and special issues will also be published.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.Benefits to authors We also provide many author benefits, such as a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
An International Journal devoted to the Physics and Chemistry of Biological PhenomenaBiophysical Chemistry publishes original work and reviews in the areas of chemistry and physics directly impacting biological phenomena. Quantitative analysis of the properties of biological macromolecules, biologically active molecules, macromolecular assemblies and cell components in terms of kinetics, thermodynamics, spatio-temporal organization, NMR and X-ray structural biology, as well as single-molecule detection represent a major focus of the journal. Theoretical and computational treatments of biomacromolecular systems, macromolecular interactions, regulatory control and systems biology are also of interest to the journal.The journal publishes Regular Articles, Reviews, Short Communications (maximum of 4 printed pages) and Feature Articles. Feature Articles are normally by Editor's invitation only, but interested authors can contact the Editors before submission. Author(s) will be asked to focus on her/his recent research contributions, thereby adding a personal perspective to their field of research. These short reviews will include the authors' photo and a brief bio/CV and will have a page limit of 5 printed pages in print.Manuscripts that fall outside the scopes and interests of the journal are returned to the Authors without in-depth review. Relevant manuscripts are reviewed expeditiously with decisions generally made within 3 weeks from receipt. Short Communications are 6 printed pages maximum, reporting results of unusual timeliness and significance. Letters are short articles (6 printed pages maximum) reporting results of unusual timeliness and significance. Decisions on Short Communications are made within 1-2 weeks from receipt and publication is offered only to manuscripts requiring minor revision. Reviews are published by invitation from the Editors, but suggestions are welcome at any time. Authors can now submit supplementary material for online publication on ScienceDirect http://www.sciencedirect.com/science/journal/03014622. See our Guide for Authors https://www.elsevier.com/journals/biophysical-chemistry/0301-4622/guide-for-authors for more information.
The mission of Biophysical Journal (BJ) is to publish the highest quality work that elucidates important biological, chemical, or physical mechanisms and provides quantitative insight into fundamental problems at the molecular, cellular, and systems and whole-organism levels. Articles published in the Journal should be of general interest to quantitative biologists, regardless of their research specialty.BJ publishes original articles, letters, and perspectives on important problems in modern biophysics. The papers should be written so as to be of interest to a broad community of biophysicists. BJ welcomes experimental studies that employ quantitative physical approaches for the study of biological systems, including or spanning scales from molecule to whole organism. Experimental studies of a purely descriptive or phenomenological nature, with no theoretical or mechanistic underpinning, are not appropriate for publication in BJ. Theoretical studies should offer new insights into the understanding ofexperimental results or suggest new experimentally testable hypotheses. Articles reporting significant methodological or technological advances, which have potential to open new areas of biophysical investigation, are also suitable for publication in BJ. Papers describing improvements in accuracy or speed of existing methods or extra detail within methods described previously are not suitable for BJ.Papers are handled by an Editorial Board of more than 100 scientists who solicit reviewers with the requisite expertise. The Editorial Board is divided among the following sections; these descriptions also serve to detail the scope of science published by BJ: Section I - Nucleic Acids and Genomic Biophysics. This section highlights biophysical aspects of genome organization and their relation to cellular functions such as transcription, translation, development, and gene-regulatory mechanisms. It includes studies using experimental and computational techniques to investigate the structure, dynamics, function, and regulation of DNA, RNA, and their complexes with other molecules. It also publishes research studies on chromatin structural states, folding and function, and the dynamic organization of the nucleus.Section II -Proteins. This section covers the biophysics of protein structure, function, and interactions. The emphasis is on molecular biophysics encompassing experimental, computational, and theoretical approaches.Section III - Channels and Transporters. This section covers mechanistic studies of the structure, function, and regulation of membrane transport proteins and signaling receptors. The emphasis is on studies that use experimental and/or computational methods.Section IV - Membranes. This section covers the analysis of the structure, organization, and function of artificial and biological membranes via state-of-the art experimental and theoretical biophysics approaches.Section V - Molecular Machines, Motors, and Nanoscale Biophysics. This section covers biophysical studies of molecular motors (cytoskeletal and non-cytoskeletal), cytoskeletal assemblies, and muscle contraction and studies that use single-molecule tracking, force spectroscopy, and other nanoscale techniques.Section VI - Cell Biophysics. This section covers work that furthers our understanding of molecular function and interactions within and between cells and elucidates how these mechanisms are regulated within the cellular milieu.Section VII - Systems Biophysics. This section covers the analysis of collective properties in systems of interacting components, including biomolecular networks, organelles, tissues, organs, and whole organisms. Special emphasis is placed on studies that link multiple levels of biological organization, from gene sequence to nonlinear and network-level phenomena, such as pattern formation, metabolism, and signal transduction.Section VIII - Biophysical Perspectives.Visit the Cell Press website for more information about Biophysical Journal - http://www.cell.com/biophysj/home
Biosensors & Bioelectronics has an open access companion journal Biosensors &Bioelectronics: X . To submit to Biosensors & Bioelectronics: X visit https://www.editorialmanager.com/BIOSX/default.aspx.Biosensors are defined as analytical devices incorporating a biological material, a biologically derived material or a biomimic intimately associated with or integrated within a physicochemical transducer or transducing microsystem, which may be optical, electrochemical, thermometric, piezoelectric, magnetic or micromechanical (Turner et al., 1987; Turner, 1989). Biosensors & Bioelectronics is the principal international journal devoted to research, design, development and application of biosensors and bioelectronics. It is an interdisciplinary journal serving professionals with an interest in the exploitation of biological materials and designs in novel diagnostic and electronic devices including sensors, DNA chips, electronic noses, lab-on-a-chip and μ-TAS. Biosensors usually yield a digital electronic signal which is proportional to the concentration of a specific analyte or group of analytes. While the signal may in principle be continuous, devices can be configured to yield single measurements to meet specific market requirements. Examples of Biosensors include immunosensors, enzyme-based biosensors, organism- and whole cell-based biosensors. They have been applied to a wide variety of analytical problems including uses in medicine, biomedical research, drug discovery, the environment, food, process industries, security and defence. The design and study of molecular and supramolecular structures with molecular biorecognition and biomimetic properties for use in analytical devices is also included within the scope of the journal. Here the focus is on the complementary intersection between molecular recognition, nanotechnology, molecular imprinting and supramolecular chemistry to improve the analytical performance and robustness of devices.The emerging field of Bioelectronics seeks to exploit biology in conjunction with electronics in a wider context encompassing, for example, biological fuel cells, bionics and biomaterials for information processing, information storage, electronic components and actuators. A key aspect is the interface between biological materials and micro- and nano-electronics.While endeavouring to maintain coherence in the scope of the journal, the editors will accept reviews and papers of obvious relevance to the community, which describe important new concepts, underpin understanding of the field or provide important insights into the practical application, manufacture and commercialisation of biosensors and bioelectronics.
Biosystems Engineering publishes research in engineering and the physical sciences that represent advances in the understanding and management of the performance of biological systems for sustainable developments in land use and the environment, agriculture and amenity, bioproduction processes and the food chain. The subject matter of the journal reflects the wide range and interdisciplinary nature of research in engineering for biological systems. Papers may report the results of experiments, modelling, theoretical analyses, data driven findings, design of, or innovations relating to, machines and mechanisation systems, processes or processing methods, equipment and buildings, experimental equipment, laboratory and analytical techniques and instrumentation. Submissions should (1) involve new engineering science insights, including novel characteristics that can advance the specific scientific field; (2) present existing similar work in its field and discuss the advance over the state of the art offered, and (3) illustrate the knowledge gap that the work seeks to fill. The novelty aspect is of crucial importance for our Journal, and it is also linked with our focus on Science4Impact. Please see 3.3. for more information.Biosystems Engineering does NOT wish to publish:research that does not include sufficient novelty and engineering insights that could provide advances in the specific scientific field;findings obtained under conditions which are not sufficiently representative of practice, making the usefulness of the results and conclusions not well demonstrated;application of Artificial Intelligence (AI) and Machine Learning (ML) or Deep Learning (DL) techniques, without operational implementation and/or analysis of their impact on the specific biological application under investigation;results from non-validated models, primarily based on assumptions;work where the novelty is centred on property testing of products being processed using standard techniques;calibration and verification results using well-known approaches for a specific application.
Research ReviewsBiotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are emphasized. Submissions of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
BCMD is interested in contributions in basic, translational and clinical research focusing on the biology of blood cells and the pathophysiology of blood disorders, with a specific interest in non-malignant conditions.We will consider studies on hematological malignancies when secondary to inherited or acquired bone marrow failure or disorders of the immune system.Research Areas include:Erythropoiesis, Erythrocyte Biology, Hemoglobin and its disordersMyelopoiesis, myeloid cells and disorders of the myeloid lineage (incl. myeloproliferative disorders)Megakaryopoiesis and platelet disordersHemostasis & Thrombosis and disorders of coagulationTransfusion medicine and the study of therapeutic blood products (including novel biotechnologies related to transfusion products)Bone marrow failure (severe aplastic anemia, myelodysplasia, etc.)Immunodeficiency and dysregulation of the immune systemAuto-immune disorders relating to blood